UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis

Journal of clinical oncology, 2019-10, Vol.37 (30), p.2738-2745

2019

Link zum Volltext

Verfügbarkeit prüfen

Differential prognostic effect of systemic inflammation in patients with non–small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial

Cancer, 2022-08, Vol.128 (16), p.3067-3079

2022

Link zum Volltext

Verfügbarkeit prüfen

The Effect of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Outcomes in Patients With Cancer: A Systematic Review and Meta-Analysis

The American journal of cardiology, 2024-04, Vol.216, p.87-90

2024

Link zum Volltext

Verfügbarkeit prüfen

Statins for Primary Prevention of Anthracycline Chemotherapy-Related Cardiac Dysfunction: A Systematic Review and Meta-analysis of Randomized Controlled Trials

The American journal of cardiology, 2023-11, Vol.206, p.63-66

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of race and socioeconomic factors on outcome in hepatocellular carcinoma

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e16657-e16657

2020

Link zum Volltext

Verfügbarkeit prüfen

Synchronous brain metastasis and impact of primary tumor side in colorectal cancers

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.712-712

2019

Link zum Volltext

Verfügbarkeit prüfen

Metastatic pattern and tumor sidedness in colorectal cancer

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e15147-e15147

2019

Link zum Volltext

Verfügbarkeit prüfen

Reply to S. Rossi et al and P. Palassin et al

Journal of clinical oncology, 2023-02, Vol.41 (5), p.1157-1158

2023

Link zum Volltext

Verfügbarkeit prüfen

Benchmarking mismatch repair testing for patients with cancer receiving immunotherapy

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.179-179

2024

Link zum Volltext

Verfügbarkeit prüfen

Characterizing the landscape of RING-type E3 ubiquitin transferase-altered ( RNF43 alt) colorectal cancer (CRC) and defining unique subsets with potential therapeutic vulnerabilities in microsatellite instability-high (MSI-H) CRC

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3134-3134

2023

Link zum Volltext

Verfügbarkeit prüfen

Stimulator of interferon gene (STING) expression as a biomarker for overall survival in PDL1-negative, TMB-low non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.9120-9120

2023

Link zum Volltext

Verfügbarkeit prüfen

Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer Institute-Cancer Therapy Evaluation Program

Journal of clinical oncology, 2022-10, Vol.40 (29), p.3439-3452

2022

Link zum Volltext

Verfügbarkeit prüfen

Immune checkpoint inhibitor–induced diabetes mellitus across NCI trials

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.2668-2668

2022

Link zum Volltext

Verfügbarkeit prüfen

First-in-human, phase 1, open-label, dose-escalation, dose-expansion study of ADCT-901 as monotherapy in patients with select advanced solid tumors

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS3157-TPS3157

2022

Link zum Volltext

Verfügbarkeit prüfen

Differential prognostic effect of systemic inflammation in patients with NSCLC treated with immunotherapy or chemotherapy: A post hoc analysis of the phase III OAK trial

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.9056-9056

2022

Link zum Volltext

Verfügbarkeit prüfen

Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors

Clinical cancer research, 2021-07, Vol.27 (14), p.3834-3844

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1691: Clinical characteristics influencing survival in stage-IV non-small cell lung cancer treated with nivolumab: A single-institutional experience

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.1691-1691

2018

Link zum Volltext

Verfügbarkeit prüfen

Neuroendocrine carcinoma of luminal gastrointestinal tract

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e16186-e16186

2018

Link zum Volltext

Verfügbarkeit prüfen

National practice pattern and outcome of very early breast cancer

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e12530-e12530

2018

Link zum Volltext

Verfügbarkeit prüfen

Age-associated differences in transcriptional expression and tumor immune microenvironment composition among older patients with cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.2633-2633

2022

Link zum Volltext

Verfügbarkeit prüfen

Major adverse cardiac events (MACE) with immune checkpoint inhibitor (ICI)-based therapies for cancer: A pooled analysis of investigational clinical trials sponsored by the National Cancer Institute Cancer Therapy Evaluation Program (NCI-CTEP) in the United States and Canada

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.2508-2508

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of immune checkpoint inhibitors in patients with HIV-associated unresectable HCC (uHCC): Propensity-score matched analyses from two international consortia

Journal of clinical oncology, 2024-01, Vol.42 (3_suppl), p.442-442

2024

Link zum Volltext

Verfügbarkeit prüfen

Survival stratification using a baseline inflammatory physiology based scoring system in advanced non-small cell lung cancer (NSCLC) treated with anti-programmed cell death-1 (anti-PD-1) therapy

Journal of clinical oncology, 2018-02, Vol.36 (5_suppl), p.152-152

2018

Link zum Volltext

Verfügbarkeit prüfen

SIDE in metastatic colon cancer: SEER Database analysis

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.753-753

2018

Link zum Volltext

Verfügbarkeit prüfen

Real-world use of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.393-393

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 57

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

KollektionPublisher website

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(57)

Sprache

Englisch
(57)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(48)
Cancer Research
(3)
Clinical Cancer Research
(2)
The American Journal Of Cardiology
(2)
Cancer
(1)
The American Journal Of Gastroenterology
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Resumption of Immune Checkpoint Inhibitor Therapy After Immune-Mediated Colitis

Differential prognostic effect of systemic inflammation in patients with non–small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial

The Effect of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Outcomes in Patients With Cancer: A Systematic Review and Meta-Analysis

Statins for Primary Prevention of Anthracycline Chemotherapy-Related Cardiac Dysfunction: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Impact of race and socioeconomic factors on outcome in hepatocellular carcinoma

Synchronous brain metastasis and impact of primary tumor side in colorectal cancers

Metastatic pattern and tumor sidedness in colorectal cancer

Reply to S. Rossi et al and P. Palassin et al

Benchmarking mismatch repair testing for patients with cancer receiving immunotherapy

Characterizing the landscape of RING-type E3 ubiquitin transferase-altered ( RNF43 alt) colorectal cancer (CRC) and defining unique subsets with potential therapeutic vulnerabilities in microsatellite instability-high (MSI-H) CRC

Stimulator of interferon gene (STING) expression as a biomarker for overall survival in PDL1-negative, TMB-low non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs)

Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer Institute-Cancer Therapy Evaluation Program

Immune checkpoint inhibitor–induced diabetes mellitus across NCI trials

First-in-human, phase 1, open-label, dose-escalation, dose-expansion study of ADCT-901 as monotherapy in patients with select advanced solid tumors

Differential prognostic effect of systemic inflammation in patients with NSCLC treated with immunotherapy or chemotherapy: A post hoc analysis of the phase III OAK trial

Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors

Abstract 1691: Clinical characteristics influencing survival in stage-IV non-small cell lung cancer treated with nivolumab: A single-institutional experience

Neuroendocrine carcinoma of luminal gastrointestinal tract

National practice pattern and outcome of very early breast cancer

Age-associated differences in transcriptional expression and tumor immune microenvironment composition among older patients with cancer

Major adverse cardiac events (MACE) with immune checkpoint inhibitor (ICI)-based therapies for cancer: A pooled analysis of investigational clinical trials sponsored by the National Cancer Institute Cancer Therapy Evaluation Program (NCI-CTEP) in the United States and Canada

Efficacy of immune checkpoint inhibitors in patients with HIV-associated unresectable HCC (uHCC): Propensity-score matched analyses from two international consortia

Survival stratification using a baseline inflammatory physiology based scoring system in advanced non-small cell lung cancer (NSCLC) treated with anti-programmed cell death-1 (anti-PD-1) therapy

SIDE in metastatic colon cancer: SEER Database analysis

Real-world use of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis

Aktive Filter

Suchergebnisse filtern